These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 9289255

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D, Pesle B, Baldini E, Rimbourg H, Darphin F, Cohen N, Brichetti A, Follana R.
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R.
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of hepatitis B surface antigen, anti-hepatitis C virus and anti-human immunodeficiency virus antibodies and syphilis seropositivity in blood donors: six years' seropositivity.
    Gunduz T, Mumcuoglu I, Güray M.
    Int J Clin Pharmacol Res; 2005 Jun; 25(3):155-8. PubMed ID: 16366424
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil.
    Treitinger A, Spada C, Ferreira LA, Neto MS, Reis M, Verdi JC, de Miranda AF, de Oliveira OV, Van der Sander Silveira M, Abdalla DS.
    Braz J Infect Dis; 2000 Aug; 4(4):192-6. PubMed ID: 11008223
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia.
    Ol HS, Bjoerkvoll B, Sothy S, Van Heng Y, Hoel H, Husebekk A, Gutteberg T, Larsen S, Husum H.
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):963-71. PubMed ID: 19842380
    [Abstract] [Full Text] [Related]

  • 13. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O, Ejele OA, Nwauche CA.
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
    Irani-Hakime N, Musharrafieh U, Samaha H, Almawi WY.
    Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
    Egah DZ, Banwat EB, Audu ES, Iya D, Mandong BM, Anele AA, Gomwalk NE.
    East Mediterr Health J; 2007 May; 13(4):961-6. PubMed ID: 17955779
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of hepatitis B and C and blood donors.
    Mehdi SR, Pophali A, Al-Abdul Rahim KA.
    Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.